Cancer Innovations at MIT

MIT is at the forefront of developing novel strategies for cancers that predominantly affect women, leveraging AI, nanotechnology, and advanced imaging.

Wearable Breast Cancer Detection

Dr. Canan Dagdeviren and her Conformable Decoders group are creating a revolutionary wearable ultrasound patch, like an “ultrasound bra” (cUSBr-Patch), for more frequent, at-home breast cancer screening, aiming for earlier detection, especially for high-risk individuals. This work is supported by the MIT Center for Clinical and Translational Research (CCTR).
MORE

AI for Breast Cancer Risk Prediction

Director of the MIT Jameel Clinic, is developing AI models that analyze mammograms to predict future breast cancer risk with greater accuracy, potentially identifying tumors years before traditional diagnosis.
MORE

Nanoelectronics for Brain Metastasis 

Nano-Cybernetic Biotrek Lab is engineering radical nanoelectronic interventions to treat breast cancer brain metastasis (BCBM), a devastating complication with currently no cure, showing promise in preclinical models.
MORE

Early Ovarian Cancer Detection with Nanoparticles

Sangeeta N. Bhatia’s lab designs “synthetic biomarkers”—nanoparticles that interact with tumor proteins to release detectable fragments in urine, potentially diagnosing ovarian cancer months earlier than current methods.
MORE

Visualizing Tiny Ovarian Tumors

Angela Belcher’s lab, in collaboration with Lincoln Laboratory, uses fluorescent carbon nanotubes to help surgeons see and remove tiny ovarian tumors, improving surgical outcomes.
MORE

Intraoperative Tumor Detection

The FDA-approved Lumicell technology, for detecting residual tumor cells during breast cancer surgery, originated from a Koch Institute pilot project involving, Professor Linda Griffith, and David Lee.
MORE